Use of atomoxetine in children and adolescents with ADHD
Progress in Neurology and Psychiatry · 2009
DOI: 10.1002/pnp.114 ↗Abstract
Abstract Atomoxetine is a non‐stimulant drug licensed for use in the treatment of attention deficit‐hyperactivity disorder (ADHD).Dr Banerjee describes a study that was carried out over a two‐year period in the three ADHD clinics in East Kent Hospitals NHS Trust to evaluate the current practice on the use of atomoxetine in ADHD in children and adolescents. Copyright © 2009 Wiley Interface Ltd
EUVIMED